Patients who received Abbott Laboratories' novel dissolving vascular stent had a significantly higher rate of serious adverse heart events than those treated with the company's widely used Xience drug ...

Sutter Medical Center, Sacramento and Mills-Peninsula Health Services, both affiliates of Sutter Health, will be among the first in the country to offer patients with coronary artery disease a new ...

LONDON, Abbott announced today positive one-year clinical results from ABSORB Japan, a multi-center, randomized trial comparing the safety and effectiveness of Abbott's fully dissolving Absorb™ heart ...

For decades, treating coronary heart disease involved using tiny metal stents to prop open clogged arteries in the heart. Once they're in, they don't come out, which doctors say can cause problems.

Now you see it, now you don't. A new type of heart stent that works like dissolving stitches, slowly going away after it has done its job, passed its first major test in a large study, doctors said ...

An Abbott device that failed heart disease patients is getting a new life in patients with severe vascular disease. The device is a below-knee stent that widens clogged blood vessels, and then ...

WASHINGTON (AP) -- A disappearing medical implant will get a closer look from the Food and Drug Administration this week. The FDA meets on Tuesday to review Abbott Laboratories' first-of-a-kind heart ...

GRAND RAPIDS, Mich. (WOOD) — Cardiologists in West Michigan are working with a new tool — a tool that disappears. It’s a new kind of heart stent the body eventually absorbs. “This basically represents ...

(Reuters) - Abbott's Absorb dissolving heart stent proved as safe and effective one year after being placed in a diseased artery as the company's market-leading Xience drug coated metal stent with a ...

Coronary artery disease affects 15 million Americans and remains the leading cause of death, killing more than 610,000 annually. The FDA has approved a new type of stent that dissolves over time, and ...

WASHINGTON (Reuters) - Patients who received Abbott Laboratories' novel dissolving vascular stent had a significantly higher rate of serious adverse heart events than those treated with the company's ...